228 related articles for article (PubMed ID: 23685424)
1. The influence of radioiodine therapy on ocular changes and their relation to urine cotinine level in patients with Graves' Ophthalmopathy.
Czarnywojtek A; Zgorzalewicz-Stachowiak M; Budny B; Wasko R; Florek E; Szczepanek E; Komar-Rychlicka K; Waligorska-Stachura J; Kurdybacha P; Miechowicz I; Ruchala M
Neuro Endocrinol Lett; 2013; 34(3):241-8. PubMed ID: 23685424
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of radioiodine therapy for mild Graves ophthalmopathy depending on cigarette consumption: a 6‑month follow‑up.
Czarnywojtek A; Komar-Rychlicka K; Zgorzalewicz-Stachowiak M; Sawicka-Gutaj N; Woliński K; Gut P; Płazinska M; Torlińska B; Florek E; Waligórska-Stachura J; Ruchała M
Pol Arch Med Wewn; 2016 Aug; 126(10):746-753. PubMed ID: 27534827
[TBL] [Abstract][Full Text] [Related]
3. [The level of cotinine - marker of tobacco smoking, in patients with hyperthyroidism].
Czarnywojtek A; Zgorzalewicz-Stachowiak M; Florek E; Piekoszewski W; Warmuz-Stangierska I; Kulińska-Niedziela I; Komar-Rychlicka K; Sowiński J
Endokrynol Pol; 2006; 57(6):612-8. PubMed ID: 17253434
[TBL] [Abstract][Full Text] [Related]
4. Radioiodine therapy and Graves' disease - Myths and reality.
Plazinska MT; Sawicka-Gutaj N; Czarnywojtek A; Wolinski K; Kobylecka M; Karlińska M; Prasek K; Zgorzalewicz-Stachowiak M; Borowska M; Gut P; Ruchala M; Krolicki L
PLoS One; 2020; 15(1):e0226495. PubMed ID: 31929534
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
6. Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.
Chen DY; Schneider PF; Zhang XS; Luo XY; He ZM; Chen TH
Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):1-6. PubMed ID: 24203649
[TBL] [Abstract][Full Text] [Related]
7. Radioiodine therapy and Graves' ophthalmopathy.
Sisson JC; Schipper MJ; Nelson CC; Freitas JE; Frueh BR
J Nucl Med; 2008 Jun; 49(6):923-30. PubMed ID: 18483104
[TBL] [Abstract][Full Text] [Related]
8. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine therapy of Graves' hyperthyroidism in patients without pre-existing ophthalmopathy: can glucocorticoids prevent the development of new ophthalmopathy?
Dederichs B; Dietlein M; Jenniches-Kloth B; Schmidt M; Theissen P; Moka D; Schicha H
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):366-70. PubMed ID: 16915539
[TBL] [Abstract][Full Text] [Related]
10. [Interaction between cigarette smoking and glucocorticoids therapy and therapeutic doses of radioiodine (131I) in patients with Graves’ disease].
Płazińska MT; Prasek K; Czarnywojtek A; Sawicka-Gutaj N; Woliński K; Borowska M; Kobylecka M; Florek E; Faryna M; Królicki L
Przegl Lek; 2016; 73(10):766-72. PubMed ID: 29689681
[TBL] [Abstract][Full Text] [Related]
11. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission.
Eckstein AK; Lax H; Lösch C; Glowacka D; Plicht M; Mann K; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2007 Oct; 67(4):607-12. PubMed ID: 17880407
[TBL] [Abstract][Full Text] [Related]
12. Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study.
Lai A; Sassi L; Compri E; Marino F; Sivelli P; Piantanida E; Tanda ML; Bartalena L
J Clin Endocrinol Metab; 2010 Mar; 95(3):1333-7. PubMed ID: 20061414
[TBL] [Abstract][Full Text] [Related]
13. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism.
Bartalena L; Marcocci C; Bogazzi F; Panicucci M; Lepri A; Pinchera A
N Engl J Med; 1989 Nov; 321(20):1349-52. PubMed ID: 2811943
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment.
Villagelin D; Romaldini JH; Santos RB; Milkos AB; Ward LS
Thyroid; 2015 Dec; 25(12):1282-90. PubMed ID: 26414885
[TBL] [Abstract][Full Text] [Related]
15. Clinical update: treatment of hyperthyroidism in Graves' ophthalmopathy.
Azzam I; Tordjman K
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():193-7. PubMed ID: 20467362
[TBL] [Abstract][Full Text] [Related]
16. The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy.
Lacka K; Manuszewska E; Korczowska I; Lacki JK
Curr Eye Res; 2007 Mar; 32(3):291-7. PubMed ID: 17453949
[TBL] [Abstract][Full Text] [Related]
17. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
18. Clinical correlation between the consumption of nicotine and cotinine concentrations in urine and serum by competitive enzyme-linked immunosorbent assay.
Ziegler UE; Kauczok J; Dietz UA; Reith HB; Schmidt K
Pharmacology; 2004 Dec; 72(4):254-9. PubMed ID: 15539886
[TBL] [Abstract][Full Text] [Related]
19. Cell proliferation kinetics and genotoxicity in lymphocytes of smokers living in Mexico City.
Calderón-Ezquerro C; Sánchez-Reyes A; Sansores RH; Villalobos-Pietrini R; Amador-Muñoz O; Guerrero-Guerra C; Calderón-Segura ME; Uribe-Hernández R; Gómez-Arroyo S
Hum Exp Toxicol; 2007 Sep; 26(9):715-22. PubMed ID: 17984142
[TBL] [Abstract][Full Text] [Related]
20. [Urinary cotinine in patients with hyperthyroidism].
Czarnywojtek A; Rabska-Pietrzak B; Ruchała M; Florek E; Piekoszewski W; Warmuz-Stangierska I; Michałek K; Sowiński J
Przegl Lek; 2005; 62(10):1010-2. PubMed ID: 16521942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
